Cargando…

Weaning from concentrated ascites reinfusion therapy for refractory ascites by SGLT2 inhibitor

Detalles Bibliográficos
Autores principales:	Miyamoto, Yasunori, Honda, Akira, Yokose, Seiji, Nagata, Mariko, Miyamoto, Jiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967662/ https://www.ncbi.nlm.nih.gov/pubmed/35371450 http://dx.doi.org/10.1093/ckj/sfab266

Ejemplares similares

The Effects of SGLT2 Inhibitors on Liver Cirrhosis Patients with Refractory Ascites: A Literature Review
por: Miyamoto, Yasunori, et al.
Publicado: (2023)

Ascites reinfusion dialysis of refractory ascites as a bridge to kidney and liver transplantation in a patient on hemodialysis
por: Chang, Kyung Yoon, et al.
Publicado: (2017)

Cell-free and Concentrated Ascites Reinfusion Therapy for Refractory Ascites in Cirrhosis in Post-marketing Surveillance and the Role of Tolvaptan
por: Iwasa, Motoh, et al.
Publicado: (2019)

SGLT2 Inhibitors: A New Dawn for Recurrent/Refractory Cirrhotic Ascites
por: Gao, Yuan, et al.
Publicado: (2021)

Ultrastructural observation of filtration membrane in cell‐free and concentrated ascites reinfusion therapy for malignant ascites
por: Koga, Kenichi, et al.
Publicado: (2021)

Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in refractory ascites: Post-marketing surveillance results
por: Hanafusa, Norio, et al.
Publicado: (2017)

Reinfusion of ascites during hemodialysis as a treatment of massive refractory ascites and acute renal failure
por: Hsu, Ta-Wei, et al.
Publicado: (2011)

Cell-Free and Concentrated Ascites Reinfusion Therapy during Hemodialysis for Intradialytic Hypotension and Intractable Ascites
por: Hayasaka, Hideyuki, et al.
Publicado: (2022)

Feasibility of a fast-track randomized controlled trial of cell-free and concentrated ascites reinfusion therapy for patients with refractory malignant ascites
por: Yokomichi, Naosuke, et al.
Publicado: (2022)

Proliferative Glomerulonephritis with Monoclonal IgG Deposits and Refractory Ascites: Successful Treatment with Rituximab and Cell-free and Concentrated Ascites Reinfusion Therapy
por: Takami, Norito, et al.
Publicado: (2022)

Cell-free and concentrated ascites reinfusion therapy for refractory massive cardiac ascites in an adult with single ventricle haemodynamics: a case report
por: Tsukishiro, Yasue, et al.
Publicado: (2023)

Effectiveness of Cell-Free and Concentrated Ascites Reinfusion Therapy in the Treatment of Malignancy-Related Ascites: A Systematic Review and Meta-Analysis
por: Chen, Hao, et al.
Publicado: (2021)

A Case of Cell-Free and Concentrated Ascites Reinfusion Therapy Effective for Refractory Ascites in Spontaneous Bacterial Peritonitis in a Renal Transplant Patient
por: Maeda, Atsuhiro, et al.
Publicado: (2012)

Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experience
por: Tsubokura, Misato, et al.
Publicado: (2022)

Development of a novel automatic ascites filtration and concentration equipment with multi‐ring‐type roller pump units for cell‐free and concentrated ascites reinfusion therapy
por: Okahisa, Toshiya, et al.
Publicado: (2020)

Verification of serum albumin elevating effect of cell-free and concentrated ascites reinfusion therapy for ascites patients: a retrospective controlled cohort study
por: Yamada, Yosuke, et al.
Publicado: (2019)

Comment on ‘Ascitic Fluid Analysis in the Differential Diagnosis of Ascites: Focus on Cirrhotic Ascites’
por: Ahmed, Furqan
Publicado: (2017)

Ascites management by cell-free concentrated ascites reinfusion therapy during recovery from drug-induced acute liver injury: a case report
por: Yasuda, Koya, et al.
Publicado: (2020)

Encapsulating peritoneal sclerosis caused by cell-free and concentrated ascites reinfusion therapy: a case report
por: Itagaki, Hideya, et al.
Publicado: (2021)

Ascites-tap Simulator for Abdominal Examination and Removal of Ascites Fluid
por: Pakzad, Bahram, et al.
Publicado: (2019)

Ascites, refractory ascites and hyponatremia in cirrhosis
por: Fortune, Brett, et al.
Publicado: (2017)

Rituximab pharmacokinetics in ascites and serum in the treatment of follicular lymphoma with massive ascites
por: Hiroshima, Yuki, et al.
Publicado: (2012)

Eradication of intractable malignant ascites by abdominocentesis, reinfusion of concentrated ascites, and adoptive immunotherapy with dendritic cells and activated killer cells in a patient with recurrent lung cancer: a case report
por: Kimura, Hideki, et al.
Publicado: (2008)

Laparoscopic bladder injury and ascites
por: Wiwanitkit, Viroj
Publicado: (2011)

Refractory Chylous Ascites
por: Soto, Rodrigo, et al.
Publicado: (2008)

Management of refractory ascites
por: Wong, Florence
Publicado: (2023)

Successful treatment of systemic AL amyloidosis with autologous hematopoietic stem cell transplantation combined with cell‐free and concentrated ascites reinfusion therapy
por: Oka, Satoko, et al.
Publicado: (2023)

Tolvaptan for the Treatment of Refractory Ascites
por: Kurosaki, Masayuki, et al.
Publicado: (2016)

Evaluation of the performance, operability, and safety of Plasauto μ, a new type of machine for cell‐free and concentrated ascites reinfusion therapy, in a postmarketing clinical study
por: Hasegawa, Midori, et al.
Publicado: (2021)

Chronic Peritoneal Drainage in Refractory Right Heart Failure and Ascites
por: Yarragudi, Rajashri, et al.
Publicado: (2022)

Treatment of refractory ascites with an automated low‐flow ascites pump in patients with cirrhosis
por: Stirnimann, G., et al.
Publicado: (2017)

LIPIODOL LYMPHANGIOGRAPHY AND EMBOLIZATION OF CHYLOUS ASCITES AFTER PANCREATODUODENECTOMY
por: Torres, Orlando Jorge Martins, et al.
Publicado: (2022)

The clinical advantage of fixed 8-mm diameter VCX stents over underdilated VTS stents is not established in refractory ascites
por: Mansour, Sohaïb, et al.
Publicado: (2021)

Clinical Features of Refractory Ascites in Outpatients
por: Caly, Wanda Regina, et al.
Publicado: (2017)

Hereditary Hemorrhagic Telangiectasia and Refractory Ascites
por: Thandassery, Ragesh B., et al.
Publicado: (2020)

Chronic lymphocytic leukemia with massive ascites: An unusual presenting manifestation
por: Gogia, Ajay, et al.
Publicado: (2014)

Contrast-enhanced EUS in the evaluation of peritoneum and omentum in undiagnosed ascites
por: Rana, Surinder Singh, et al.
Publicado: (2020)

Reply to: “The clinical advantage of fixed 8-mm diameter VCX stents over underdilated VTS stents is not established in refractory ascites”
por: Praktiknjo, Michael, et al.
Publicado: (2021)

The Demonstration of an Inhibitor of Oncolysis in the Ascitic Fluid from the Ehrlich Ascites Carcinoma
por: Hartveit, F.
Publicado: (1964)

Systemic hemodynamic and renal effects of midodrine and octreotide in cirrhotic patients with ascites
por: Kalambokis, Georgios N., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_tb4pt02nku87m7p848jltn9n81